Daicel Chiral Technologies stands at the forefront of chiral chromatography solutions, offering unparalleled expertise in the field of optical isomer separation. Our extensive and expanding portfolio of Daicel chiral stationary phases are the first choice of pharmaceutical R&D and production teams and academic researchers worldwide for unmatched quality, innovation, and performance. We help our customers succeed with expert technical support, customer service, and scalable separation services.

At the core of our offerings are Daicel chiral stationary phases, meticulously designed and engineered to deliver resolution and efficiency in separating optical isomers. Our products, including both immobilized phases and traditional coated phases, are well known for their versatility and durability. Daicel stationary phases contain chiral selectors that enable exceptional enantiorecognition of chiral compounds for a wide range of applications, meeting the needs of our customers across various industries.

Beyond our chiral solutions, Daicel offers achiral phases for the separation of complex sample mixtures, including oligonucleotides and polypeptides. One of the hallmarks of Daicel's polymeric phases is their outstanding orthogonality and selectivity, attributes crucial for tackling the most demanding separations with confidence. This unique structural design sets our polymeric phases apart, enabling them to excel where other solutions falter, and ensuring consistent, reproducible results even in the most challenging chromatographic scenarios.

As the trusted partner of choice for leading researchers and industry pioneers internationally, Daicel Chiral Technologies remains committed to redefining the boundaries of chromatographic excellence and empowering our clients to achieve their scientific ambitions with confidence.